GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,189,000 | -7.7% | 27,300 | -6.6% | 0.07% | -2.9% |
| Q4 2021 | $1,288,000 | +15.6% | 29,216 | +0.2% | 0.07% | +6.2% |
| Q3 2021 | $1,114,000 | -8.7% | 29,153 | -4.8% | 0.06% | -9.9% |
| Q2 2021 | $1,220,000 | -71.0% | 30,637 | -74.0% | 0.07% | -72.6% |
| Q1 2021 | $4,202,000 | -35.6% | 117,727 | -33.6% | 0.26% | -40.6% |
| Q4 2020 | $6,523,000 | -5.2% | 177,265 | -3.0% | 0.44% | -15.7% |
| Q3 2020 | $6,882,000 | -9.0% | 182,828 | -1.3% | 0.52% | -15.7% |
| Q2 2020 | $7,559,000 | +6.0% | 185,316 | -1.5% | 0.61% | -11.4% |
| Q1 2020 | $7,129,000 | -22.1% | 188,149 | -3.4% | 0.69% | +0.9% |
| Q4 2019 | $9,155,000 | +11.4% | 194,830 | +1.2% | 0.69% | +3.6% |
| Q3 2019 | $8,218,000 | +3.8% | 192,538 | -2.6% | 0.66% | +3.3% |
| Q2 2019 | $7,914,000 | -4.9% | 197,741 | -0.7% | 0.64% | -8.3% |
| Q1 2019 | $8,318,000 | +6.1% | 199,049 | -3.0% | 0.70% | -7.7% |
| Q4 2018 | $7,842,000 | -3.5% | 205,234 | +1.5% | 0.76% | +14.2% |
| Q3 2018 | $8,124,000 | +0.9% | 202,237 | +1.3% | 0.66% | -4.2% |
| Q2 2018 | $8,051,000 | +0.7% | 199,721 | -2.4% | 0.69% | -1.3% |
| Q1 2018 | $7,996,000 | +2.6% | 204,671 | -6.8% | 0.70% | +6.9% |
| Q4 2017 | $7,792,000 | -24.1% | 219,684 | -13.1% | 0.66% | -27.6% |
| Q3 2017 | $10,265,000 | -2.6% | 252,832 | +3.5% | 0.91% | -7.1% |
| Q2 2017 | $10,537,000 | +7.0% | 244,366 | +4.6% | 0.98% | +4.6% |
| Q1 2017 | $9,845,000 | +15.5% | 233,523 | +5.5% | 0.93% | +8.5% |
| Q4 2016 | $8,525,000 | +2.9% | 221,371 | +15.2% | 0.86% | +1.2% |
| Q3 2016 | $8,288,000 | +3.6% | 192,170 | +4.1% | 0.85% | -0.9% |
| Q2 2016 | $8,003,000 | +10.3% | 184,654 | +3.2% | 0.86% | +7.0% |
| Q1 2016 | $7,256,000 | +5.6% | 178,929 | +5.1% | 0.80% | +1.8% |
| Q4 2015 | $6,870,000 | +4.4% | 170,271 | -0.5% | 0.79% | -6.1% |
| Q3 2015 | $6,581,000 | -12.5% | 171,145 | -5.2% | 0.84% | -5.0% |
| Q2 2015 | $7,518,000 | -14.6% | 180,503 | -5.4% | 0.88% | -14.5% |
| Q1 2015 | $8,804,000 | -0.9% | 190,768 | -8.2% | 1.03% | -2.1% |
| Q4 2014 | $8,885,000 | +1.3% | 207,874 | +8.9% | 1.05% | +0.1% |
| Q3 2014 | $8,773,000 | -11.0% | 190,843 | +3.5% | 1.05% | -10.8% |
| Q2 2014 | $9,861,000 | -0.2% | 184,384 | -0.3% | 1.18% | -3.3% |
| Q1 2014 | $9,877,000 | +0.2% | 184,864 | +0.1% | 1.22% | +1.0% |
| Q4 2013 | $9,859,000 | +6.2% | 184,656 | -0.2% | 1.21% | -3.3% |
| Q3 2013 | $9,280,000 | +5.1% | 184,969 | +4.7% | 1.25% | -2.7% |
| Q2 2013 | $8,830,000 | – | 176,708 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |